​

Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?

OverviewForecastFinancialsChart

Reviva Pharmaceuticals Ownership Summary

Reviva Pharmaceuticals is owned by 31.11% institutional investors, 1.90% insiders, and 66.99% retail investors. Jpmorgan chase is the largest institutional shareholder, holding 10.85% of RVPH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.50% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals31.11%1.90%66.99%
SectorHealthcare Stocks 35.64%12.08%52.28%
IndustryBiotech Stocks 35.26%12.00%52.74%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jpmorgan chase762.24K10.85%$556.20K
Highbridge capital management762.24K10.85%$556.20K
Armistice capital592.08K8.43%$432.04K
Diadema partners lp2.51M5.03%$924.05K
Vanguard group3.20M4.40%$892.13K
Gsa capital partners llp261.90K3.73%$191.00K
Warberg asset management90.77K1.29%$66.22K
Persistent asset partners593.90K1.19%$218.91K
Renaissance43.00K0.61%$31.38K
Susquehanna group, llp202.01K0.60%$365.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Diadema partners lp2.51M0.24%$924.05K
Persistent asset partners593.90K0.15%$218.91K
Emc capital management128.41K0.03%$49.00K
Highbridge capital management762.24K0.02%$556.20K
Gsa capital partners llp261.90K0.01%$191.00K
Warberg asset management90.77K0.01%$66.22K
Armistice capital592.08K0.01%$432.04K
Pale fire capital se25.00K0.00%$32.00K
Nri wealth management lc11.38K0.00%$3.17K
Virtu financial32.91K0.00%$24.00K

Top Buyers

HolderShares% AssetsChange
Vanguard group3.20M-1.27M
Jpmorgan chase762.24K-762.24K
Highbridge capital management762.24K0.02%762.24K
Armistice capital592.08K0.01%592.08K
Gsa capital partners llp261.90K0.01%261.90K

Top Sellers

HolderShares% AssetsChange
Millennium management---2.26M
Heights capital management---1.83M
Geode capital management---1.05M
683 capital management---1.00M
Jane street group---894.75K

New Positions

HolderShares% AssetsChangeValue
Highbridge capital management762.24K0.02%762.24K$556.20K
Jpmorgan chase762.24K-762.24K$556.20K
Armistice capital592.08K0.01%592.08K$432.04K
Gsa capital partners llp261.90K0.01%261.90K$191.00K
Warberg asset management90.77K0.01%90.77K$66.22K

Sold Out

HolderChange
Tradewinds capital management-13.00
Vermillion wealth management-50.00
Activest wealth management-50.00
Qube research-50.00
Ifp advisors-200.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202628-47.17%2,184,824-80.40%3113.18%12-55.56%1427.27%
Dec 31, 202538-19.15%8,136,283-14.17%113.10%2011.11%7-36.36%
Sep 30, 202543-12.24%9,324,158-34.68%181.01%17-22.73%1011.11%
Jun 30, 202551-3.77%14,278,36798.90%439.18%22-21.43%9-
Mar 31, 2025538.16%7,348,669-4.96%224.24%29-3.33%912.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF700.44K1.50%-
Vanguard Total Stock Mkt Idx Inv59.61K1.01%-
Vanguard Institutional Extnd Mkt Idx Tr57.96K0.99%-
BlackRock Extended Equity Market Fund K27.25K0.46%-289.49K
Fidelity Extended Market Index41.49K0.32%-152.00
Blackrock Extended Mkt Fund CF18.46K0.31%1.00
Abante Quant Value FI345.41K0.29%-
Extended Equity Market Fund K27.25K0.21%-289.49K
Northern Trust Extended Eq Market Idx9.17K0.16%-39.70K
NT Ext Equity Mkt Index Fund - Lending9.17K0.16%-174.21K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q3--

RVPH Ownership FAQ

Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 31.11%, followed by 1.90% insiders and 66.99% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 35.26%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Jpmorgan chase (762.24K shares, 10.85%), Highbridge capital management (762.24K shares, 10.85%), and Armistice capital (592.08K shares, 8.43%). Together, they hold 30.14% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Reviva Pharmaceuticals.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Diadema partners lp is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 2.51M Reviva Pharmaceuticals shares, valued at 924.05K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Reviva Pharmaceuticals shares, with 1.50% of its total shares outstanding invested in 700.44K Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools